1, 2, 3, 9b-Tetrahydro-5H-imidazo[2, 1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 2: Identification of BTA9881 as a preclinical candidate. Issue 4 (15th February 2015)